Prognostic factors for persistent fatigue after COVID-19
A prospective cohort study investigated prognostic factors for persistent fatigue after mild COVID-19 infection during the first wave of the pandemic.
Low educational level, absence of a partner, high neuroticism, low resilience, high frequency of GP contact and threatening experiences in the past were prognostic factors for persistent fatigue.
When a patient presents with fatigue after COVID-19 infection and meets some of the prognostic criteria, GPs should be aware of the increased risk of fatigue becoming persistent and consider this when advising on management.
Do you have support available for patients experiencing persistent fatigue? Is this something that your PCN occupational therapy team could help with? Have a look at our Wise General Practice Story, OTs and Chronic Pain Support for inspiration (https://www.wisegp.co.uk/chronic-pain-support)!
Read more about the research informing this GEM here: https://bjgp.org/content/73/730/e340
Antivirals in high-risk patients with COVID-19
A trial aimed to establish the safety, effectiveness and cost-effectiveness of molnupirvair, an oral antiviral, for SARS-CoV-2 in vaccinated patients in the community at increased risk of morbidity and mortality from COVID-19.
Molnupiravir did not reduce the frequency of COVID-19-associated hospitalisations or death among high-risk vaccinated adults in the community.
Being a research active practice open to participating in similar trials could help improve the evidence base to combat future public health emergencies.
o What research is your practice involved in, across your PCN, regionally or nationally? If you’re not research-active, is this something you could consider?
o Could a discussion of research within general practice form a useful foundation for a GP tutorial discussion?
Read more here: